Revenue: The sum of all revenue fields included for a company's operating activities.
United Therapeutics Corporation (UTHR) had Revenue of $794.40M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
$794.40M |
$322.20M |
|
$92.50M |
|
$701.90M |
|
$411.60M |
|
$382.80M |
|
$40.70M |
|
$423.50M |
|
$423.50M |
|
$322.20M |
|
$322.20M |
|
$322.20M |
|
$322.20M |
|
$382.80M |
|
$402.60M |
|
44.90M |
|
48.60M |
|
$7.18 |
|
$6.63 |
|
| Balance Sheet Financials | |
$3.94B |
|
$1.30B |
|
$3.80B |
|
$7.74B |
|
$721.50M |
|
-- |
|
$215.20M |
|
$936.70M |
|
$6.81B |
|
$6.70B |
|
$6.81B |
|
45.08M |
|
| Cash Flow Statement Financials | |
$461.20M |
|
$-164.70M |
|
$-93.80M |
|
$1.70B |
|
$1.90B |
|
$202.70M |
|
$31.80M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.46 |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
88.36% |
|
48.19% |
|
48.19% |
|
-- |
|
53.31% |
|
40.56% |
|
$386.30M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
0.56 |
|
2.47 |
|
36.48 |
|
4.73% |
|
4.81% |
|
4.16% |
|
4.73% |
|
$151.02 |
|
$7.95 |
|
$9.49 |
|